BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang SQ, Pan SM, Liang SX, Han YS, Chen HB, Li JC. Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review). Int J Oncol 2021;58:9. [PMID: 33649830 DOI: 10.3892/ijo.2021.5188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu M, Yang L, Hou X, Wang Z, Zhang J. Human Polycomb Protein 2 (hPC2) as a Novel Independent Prognostic Marker in Nasopharyngeal Carcinoma. Cancer Manag Res 2021;13:5775-84. [PMID: 34321924 DOI: 10.2147/CMAR.S308884] [Reference Citation Analysis]
2 Ye Q, Guo J, Chen Y, Cui Z, Chen Y. Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma. Cancer Manag Res 2021;13:5793-802. [PMID: 34321926 DOI: 10.2147/CMAR.S320541] [Reference Citation Analysis]
3 Lao TD, Nguyen TN, Le TAH. Promoter Hypermethylation of Tumor Suppressor Genes Located on Short Arm of the Chromosome 3 as Potential Biomarker for the Diagnosis of Nasopharyngeal Carcinoma. Diagnostics (Basel) 2021;11:1404. [PMID: 34441339 DOI: 10.3390/diagnostics11081404] [Reference Citation Analysis]
4 Salano VE, Mwakigonja AR, Abdulshakoor A, Kahinga AA, Richard EM. Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma. JCO Glob Oncol 2021;7:1406-12. [PMID: 34546798 DOI: 10.1200/GO.21.00120] [Reference Citation Analysis]
5 Zhang SQ, Liu J, Chen HB, Dai WJ, Zhou LQ, Xie CW, Li JC. A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma. J Dent Sci 2022;17:377-88. [PMID: 35028061 DOI: 10.1016/j.jds.2021.08.017] [Reference Citation Analysis]